Navigation Links
Ben-Gurion University of the Negev initiates project to eliminate intestinal worms in Ethiopia
Date:8/5/2008

NEW YORK, August 6, 2008 A professor at The Faculty of Health Sciences at Ben-Gurion University of the Negev (BGU) is beginning an intensive program in Ethiopia this August to eradicate intestinal worms which affect as much as 50 percent of the population in Africa.

BGU Professor Zvi Bentwich, who heads the Center for Tropical Diseases and AIDS in Israel (CEMTA), believes there is a possible connection between the AIDS epidemic in Africa and intestinal worms, one of the many Neglected Tropical Diseases (NTDs) which affect nearly one quarter of the world's population.

Prof. Bentwich believes that intestinal worms can affect the immune system in such a profound way that it has a major impact on one's susceptibility to HIV and tuberculosis, and in coping with these diseases when they are already there. "As head of the largest AIDS center, I dealt with a large number of Ethiopian HIV and AIDS patients, and through them became aware of the magnitude of this problem in Ethiopia," he says.

The first stage of the operation to deworm about 30,000 people from three separate locations in Ethiopia begins in August. In the fall, the research project will focus on the town of Mekele in northern Ethiopia with approximately 250,000 inhabitants.

The program combines the provision and administration of antihelminthic medications, a few pills every four to six months, with hygiene education and information on how to protect populations from exposure to the parasites.

"NTDs are one of the most evident hallmark signs of poverty and neglect, significantly contributing to the persistence of this situation in a very large number of countries in Africa, Asia and South America," Bentwich explains. "They have been largely neglected by the Western developed countries, since they are practically nonexistent there. "It costs much less than what it takes to fight the more recognized epidemics like AIDS, tuberculosis and malaria."


'/>"/>
Contact: Andrew Lavin
andrewlavin@alavin.com
516-353-2505
American Associates, Ben-Gurion University of the Negev
Source:Eurekalert

Page: 1 2

Related medicine news :

1. NEJM: Low-fat diets not best for weight loss: New study by Ben-Gurion U. of the Negev
2. Gesture interface device developed by Ben-Gurion University of the Negev
3. University of Mississippi Health Care Selects UHC for Group Purchasing Services
4. Sweden to Receive Scandinavia's First TomoTherapy System : Lund University Hospital to Offer Swedish Cancer Patients the Most Advanced Image-Guided Radiation Therapy Treatments
5. The AMERIGROUP Foundation Honors the University of Maryland Hospital for Childrens Breathmobile
6. Watching too much TV is causing some university students to pack on the pounds
7. University of South Florida receives new multimillion award to assess juvenile diabetes treatments
8. Georgetown University Medical Center Collaborates with Indivumed to Develop Cancer Research Database
9. ARUP Laboratories and Weber State University Announce Educational Collaboration
10. The Doctors Channel Adds Esteemed Director of Minimally Invasive Urology at Columbia University to Editorial Team
11. Malaria Vaccine Developer Sanaria Inc. and the University of Maryland Biotechnology Institute Awarded Collaborative, Multi-Year, US $600,000 NIH Phase I Small Business Innovation Research Grant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... cell disease, a condition characterized by deformed and ... most common genetic blood disorders affecting millions of ... Americans.(1) Research presented today at the 51st Annual ... intriguing studies on the acute danger that the ... disorder, evaluations of both new and standard treatments ...
(Date:12/6/2009)... Internet Sleep Disorders information and Treatment site ... sleep problems with herbal or natural sleep aids ... ,insomnia remedies for a good cause. The submissions ... Natural Sleep Aids ,Encyclopedia, by YOU, to be ... The site will donate 100% of the proceeds ...
(Date:12/5/2009)... combination has shown in a phase 1/2 clinical ... the treatment of patients newly diagnosed with multiple myeloma, ... say researchers from Dana-Farber Cancer Institute. , Partial responses ... patients treated with the drug combination in the multi-center ... response rate" in the phase 2 population, reports Paul ...
(Date:12/5/2009)... South Africa, December 5 The first Football,for ... Cape Town opened its doors,today (5 December 2009). ... Cape Premier Helen Zille, 2010 FIFA World Cup ... African Football Association,President Kirsten Nematandani and Executive Mayor ...
(Date:12/5/2009)... , , SATURDAY, Dec. 5 (HealthDay News) -- They,re not ... bad reactions to certain holiday traditions and need to ... to the American College of Allergy, Asthma and Immunology ... may choose to decorate with artificial plants, but both ...
Breaking Medicine News(10 mins):Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 2Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 3Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 4Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 5Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 6Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 7Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 8Health News:Studies Investigate Emerging Trends and Treatment Options for Patients With Sickle Cell Disease 9Health News:Donate a Herbal Natural Sleep Aid to the Internet's First "Natural Sleep Aids E-book" Written by People Just Like You 2Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3Health News:Keep Asthma, Allergies at Bay for the Holidays 2
... WEDNESDAY, Nov. 14 (HealthDay News) -- A protein that may ... to be a biomarker that indicates severe asthma. And it ... according to new research. , Reporting in the Nov. 15 ... Yale University researchers said that people with severe asthma were ...
... 34 years shows parental history, overweight are markers for ... The development of type 2 diabetes in adults can ... that,s followed a group of 814 children and adults ... Center found that parental history of diabetes, as well ...
... Community Hospital of Long Beach (CHLB) is entering to win a ... The hospital that receives the most votes will win the ... taking place NOW through December 31, ... ,Community Hospital of Long Beach, from the drop ...
... prepared testimony of NCPA president Steve Giroux before the ... the counter,availability of certain drugs., "Hello, I am ... and a pharmacist from Middleport, New York., NCPA ... public meeting to,explore the public health benefit of certain ...
... Plastic Surgery Procedures, LAS VEGAS, Nov. 14 ... raised questions about the safety of plastic,surgery. The factors ... concerns over her physician,s lack of board certification and,his ... should,be reassured that Donda West,s tragic outcome is unusual," ...
... donors share in success, Governor Phil Bredesen ... Consortium headquarters, Chili,s Care Center culmination of ... care, MEMPHIS, Tenn., Nov. 14 St. ... celebrated the national,grand opening of the Chili,s Care ...
Other Medicine News:Health News:Defensive Protein Linked to Asthma 2Health News:Defensive Protein Linked to Asthma 3Health News:Adult Type 2 Diabetes Can Be Predicted in Childhood 2Health News:Community Hospital of Long Beach - Help Us Win an MRI Scanner! 2Health News:NCPA President Steve Giroux's Testimony at FDA Behind the Counter Hearing 2Health News:NCPA President Steve Giroux's Testimony at FDA Behind the Counter Hearing 3Health News:NCPA President Steve Giroux's Testimony at FDA Behind the Counter Hearing 4Health News:NCPA President Steve Giroux's Testimony at FDA Behind the Counter Hearing 5Health News:Guide to Minimizing Your Plastic Surgery Risks 2Health News:St. Jude Celebrates Next Frontier of Finding Cures With Grand Opening of Chili's Care Center 2Health News:St. Jude Celebrates Next Frontier of Finding Cures With Grand Opening of Chili's Care Center 3Health News:St. Jude Celebrates Next Frontier of Finding Cures With Grand Opening of Chili's Care Center 4
(Date:12/4/2009)... Dec. 4 The U.S. Food and ... form as an option for the treatment of schizophrenia ... disorder in adolescents aged 13-17 years old. ,, ... into consideration the increased potential for weight gain and ...
(Date:12/4/2009)... Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced that ... Principal investigators will discuss the data presentations surrounding carfilzomib ... the 51st American Society of Hematology (ASH) Annual Meeting. ... a.m. ET on Monday, December 7, 2009. The ...
(Date:12/4/2009)... Chemistry World recently highlighted a new report ... America ( PhRMA ) that identifies 97 new drugs ... The report found that the 97 products in ... either in human clinical trials or awaiting approval by the ...
Breaking Medicine Technology:FDA Approves Lilly's Zyprexa for Two Adolescent Indications 2FDA Approves Lilly's Zyprexa for Two Adolescent Indications 3FDA Approves Lilly's Zyprexa for Two Adolescent Indications 4FDA Approves Lilly's Zyprexa for Two Adolescent Indications 5FDA Approves Lilly's Zyprexa for Two Adolescent Indications 6FDA Approves Lilly's Zyprexa for Two Adolescent Indications 7Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2Management Health Solutions Inc to Exhibit at HFMA ANI 47574 1Management Health Solutions Inc to Exhibit at HFMA ANI 47574 2HealthForumOnline Offers New Online CE CEU Course on Pain Screening Instruments for Medical and Mental Health Providers 47572 1HealthForumOnline Offers New Online CE CEU Course on Pain Screening Instruments for Medical and Mental Health Providers 47572 2HealthForumOnline Offers New Online CE CEU Course on Pain Screening Instruments for Medical and Mental Health Providers 47572 3HealthForumOnline Offers New Online CE CEU Course on Pain Screening Instruments for Medical and Mental Health Providers 47572 4New Journal of Natural Medicine Launched This June Promotes Natural Therapy 47570 1New Journal of Natural Medicine Launched This June Promotes Natural Therapy 47570 2
... Provides Real-Time Insight on Viability of Infectious ... Disease Treatment Options -, ... ) today announced that the Texas A&M Health,Science Center Research Foundation ... of more effective therapeutic,treatments for tuberculosis. Research efforts and the purchase ...
... Terumo Heart, Inc. announced,a presentation at the ... "Long Term Circulatory Support with the DuraHeart(TM) ... Eligible for,Transplantation: European Experience" was delivered by ... Terumo Heart, Inc., (Photo: http://www.newscom.com/cgi-bin/prnh/20080303/CLM012 ...
Other Medicine Technology:Caliper Life Sciences' Optical Imaging Technology Selected to Aid Tuberculosis Research Efforts by the Texas A&M Health Science Center 2Terumo Heart Summarizes Results of DuraHeart(TM) LVAS Implants 2
... The RapidPCP test is an ... test. It is,designed for qualitative determination ... above,a cut-off level of 25 ng/mL. ... in the point of care location,and ...
The RapidMTD test is an immunochromatography based one step in vitro test. It is,designed for qualitative determination of methadone in human urine specimens above a,cut-off level of 300 ng/mL. The a...
The RapidBARBITURATE test is an immunochromatography based one step in vitro test. It is designed for qualitative determination of barbiturates and in human urine specimens above a cut-off level of 3...
... With membrane parasite ... and cytoplasm as antigen. ... different antigens than the ... possible to use two ...
Medicine Products: